Thema: US81750R2013
MCRB, US81750R2013
gamestop-6286878_1920.jpg - Foto: THN
Seres Therapeutics stock quoted at EUR 1.74 late on October 29
Seres Therapeutics has an upcoming results date listed for November 4. The company trades under MCRB and is identified by ISIN US81750R2013.
ad-hoc-news.de, heute 02:31 Uhr
MCRB, US81750R2013
Seres Therapeutics sets November 4 results date for MCRB ...
Nasdaq market value was USD 23.9 million on October 20, 2026. MCRB stock costs EUR 2.17 on October 20, 2026 at 7:53 p.m. CEST.
ad-hoc-news.de, 20.10.26 20:00 Uhr
MCRB, US81750R2013
Seres Therapeutics stock was last at EUR 2.22 before November ...
Second-quarter revenue was USD 736,000 on June 30, 2026, with USD 15.6 million cash. Seres Therapeutics stock was last at EUR 2.22 on October 16, 2026.
ad-hoc-news.de, 17.10.26 22:28 Uhr
MCRB, US81750R2013
Seres Therapeutics stock at EUR 2.28 USD 25.2 million market ...
The Nasdaq 52-week range stood at USD 2.38 to USD 29.98 on October 15, 2026. Seres Therapeutics stock costs EUR 2.28 on October 15, 2026.
ad-hoc-news.de, 15.10.26 22:33 Uhr
MCRB, US81750R2013
Analysts see USD 17 target for Seres Therapeutics stock
Seres Therapeutics stock traded at EUR 2.44 on October 8, 2026. It was plus 0.41 percent versus EUR 2.43, with market value at USD 26.3 million.
ad-hoc-news.de, 08.10.26 10:47 Uhr
MCRB, US81750R2013
Seres Therapeutics leaves S&P Global BMI Index. Seres Therapeutics ...
